Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
4.090
-0.060 (-1.44%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Exicure Employees
Exicure had 8 employees as of March 31, 2025. The number of employees increased by 1 or 14.29% since the number was last reported on December 31, 2024.
Employees
8
Change
1
Growth
14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,153,625
Market Cap
26.07M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Boundless Bio | 64 |
| Vistagen Therapeutics | 59 |
| Evaxion | 46 |
| Senti Biosciences | 34 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| FibroBiologics | 15 |
XCUR News
- 4 weeks ago - Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant - GlobeNewsWire
- 6 weeks ago - Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings - GlobeNewsWire
- 3 months ago - Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial - Benzinga
- 3 months ago - Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting - GlobeNewsWire
- 4 months ago - Exicure, Inc. Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting - GlobeNewsWire
- 4 months ago - Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 5 months ago - Exicure Highlights Recent Achievements and Near-term Strategic Priorities - GlobeNewsWire